MARCUS NIELSEN: Open Payments
NPI 1821311853 · SAINT PAUL, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 13 payments from 7 companies in 2025. Trend: 2023 $205 · 2024 $344 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $153 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
| PFIZER INC. | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $16 |
| Novo Nordisk Inc | 1 | $16 |
Products named: BREZTRI, FARXIGA, AUSTEDO XR, Kerendia, PREVNAR 20, YUPELRI, VOQUEZNA, Rybelsus.
Industry payments across NE — which companies pay providers there.
